<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0192030.ref044">
 <label>44</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Mupfumi</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Makamure</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Chirehwa</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Sagonda</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Zinyowera</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Mason</surname>
   <given-names>P</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Impact of Xpert MTB/RIF on antiretroviral therapy-associated tuberculosis and mortality: a pragmatic randomized controlled trial</article-title>. 
  <source>Open Forum Infectious Diseases</source>. 
  <year>2014</year>
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ofid/ofu038" xmlns:xlink="http://www.w3.org/1999/xlink">10.1093/ofid/ofu038</ext-link>
  </comment>
  <?supplied-pmid 25734106?>
  <pub-id pub-id-type="pmid">25734106</pub-id>
 </mixed-citation>
</ref>
